CallaBio helps biotech innovators advance from bench to IND with precision and speed. We specialize in non-clinical strategy and translational AI, supporting both emerging biotechs and large pharma with IND planning, CRO oversight, licensing readiness, and translational AI. From bioanalytics to AI-to-asset translation, we deliver flexible, high-impact solutions tailored to modern R&D challenges.
Core Offerings
🔹 AI-to-IND Strategy Blueprint
Mapping the path from model-generated hits to IND-enabling packages aligning experimental design, regulatory expectations, and data readiness.
🔹 Non-Clinical Gap Analysis & CRO Oversight
Closing critical gaps across PK, tox, bioanalytics, and developability while managing CROs to deliver with clarity and accountability.
🔹 Translational AI Integration
Bringing AI models into real-world decision-making by aligning in silico outputs with experimental workflows and clinical relevance.
🔹 Licensing-Readiness Support
Preparing scientific narratives, data packages, and due diligence materials that position emerging assets for partnerships or acquisition.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Burlington, Ma 01803, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Positioning of diverse targeting modalities (e.g., non-traditional biologics, bispecifics, Fc-engineering), Bioanalytical development (TK, PK, ADA assay implementation), Lead ID to DC nomination, CRO/CDO selection and oversight, Translational strategy for AI/ML-enabled discovery platforms.
- HQ
- Burlington, MA
Callabio Solutions Questions
Callabio Solutions's LinkedIn profile is https://www.linkedin.com/company/callabio-solutions
Callabio Solutions has
2 employees.
View email and phone details for 2
employees at Callabio Solutions.
Callabio Solutions's industry is
Biotechnology Research
Callabio Solutions's top competitors are
Catalystbio,
Prisys Biotechnologies,
Cranius Therapeutics,
Transcera,
First Light Diagnostics,
Minovacca,
Vaccine And Immunotherapy Center,
The Digital Loom,
Bienta,
Eci Therapeutics.
Callabio Solutions's categories are Biotechnology Research
Callabio Solutions's founding year is 2024
